Bharat Parenterals Ltd Share Price

Q: What is the share price of Bharat Parenterals Ltd today?

Bharat Parenterals Ltd share price as on 18 Mar 2025 is ₹1013.15

Pharmaceuticals

BSE: 541096 Small Cap ISIN: INE365Y01019

As on 18 March 2025 at 21:26 IST

₹1,013.15

+ 14.75

(1.48%)

Sell Buy

Over 1 Month

0.66%

Over 6 Months

-37.99%

Over 1 Year

-14.26%

Over 3 Years

206.16%

Bharat Parenterals Ltd Summary

Close ₹1,013.15

Open ₹993.45

High ₹1,048

Low ₹980

Volume 11,157

Net Turnover (in Cr) ₹1.14

52Wk High ₹1,870

52Wk Low ₹802

52Wk High / Low

802

1,870

Bharat Parenterals Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹698.26

EPS (TTM) 39.52

Book Value (BV) 548.29

Div. Yield 0.08 %

P/E (TTM) 25.64

Price/Book Value 1.85

Delivery % 100 %

Face Value 10

Key Ratios

PE Ratio 28.91

PB Ratio 3.06

EV to Sales 2.87

PEG Ratio -3.67

ROA 7.56

ROE 11.16

Debt-Equity 0.32

Net Profit Margin 7.98

Operating Profit Margin 14.52

Bharat Parenterals Ltd Financials

Profit and Loss

Consolidated

Standalone

Yearly

Quarterly

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	265.95	229.72	219.79	213.32	239.66
Total Expenses	247.23	206.17	191.92	186.19	206.86
Profit Before Tax	18.72	23.55	27.88	27.12	32.80
Profit After Tax	10.51	15.71	20.81	20.32	24.14
Operating Profit after Depreciation	21.95	25.73	28.77	27.52	33.66

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	210.52	41.19	39.75	43.36	31.75
Total Non Current Assets	243.91	166.06	82.32	50.63	55.88
Total Current Assets	259.91	184.28	143.74	148.02	131.62
TOTAL ASSETS	503.82	350.34	226.06	198.65	187.50
Total Shareholder's Fund	197.27	182.80	165.82	143.87	118.19

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	-4.71	21.66	-1.07	24.45	14.45
Net Cash used in Investing Activities	-104.78	-77.82	-6.63	-43.37	-12.60
Net Cash used in Financing Activities	110.43	60.60	9.42	10.50	-2.82

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	266.11	236.82	219.79	212.34	237.81
Total Expenses	235.31	204.65	191.42	185.32	202.86
Profit Before Tax	30.80	32.17	28.37	27.02	34.95
Profit After Tax	22.59	24.34	21.30	20.21	26.30
Operating Profit after Depreciation	33.99	34.36	29.34	27.41	35.82

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	38.47	35.28	39.75	43.36	31.75
Total Non Current Assets	168.99	133.51	74.64	49.21	56.12
Total Current Assets	218.16	174.51	143.36	147.02	136.18
TOTAL ASSETS	387.15	308.03	218	196.24	192.30
Total Shareholder's Fund	213.61	191.06	166.15	143.94	123.14

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	-22.92	-11.56	-22.08	21.87	14.48
Net Cash used in Investing Activities	-16.10	-13.95	21.76	-40.71	-12.60
Net Cash used in Financing Activities	34.17	28.52	2.24	10.55	-3.07

Particulars (in ₹ Cr.)	2024-12	2024-09	2024-06	2024-03	2023-12
Total Revenue	72.26	71.63	92.51	67.82	59.82
Total Expenses	68.61	79.29	88.02	66.82	53.21
Profit Before Tax	-5.50	-15.37	-4.77	-1.36	5.47
Profit After Tax	-7.87	-17.52	-8.84	-2.56	3.64
Operating Profit after Depreciation	6.59	-3.45	7.03	3.64	7.87

Particulars (in ₹ Cr.)	2024-12	2024-09	2024-06	2024-03	2023-12
Total Revenue	67.34	64.45	92.06	65.64	58.80
Total Expenses	58.99	58.79	77.07	61.90	52.02
Profit Before Tax	8.87	7.63	16.26	4.28	6.90
Profit After Tax	6.50	5.49	12.18	3.07	5.07
Operating Profit after Depreciation	12.14	10.26	18.89	6.98	9.18

Bharat Parenterals Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 968.65

S2 938.90

S3 891.80

Pivot 1,015.75

R1 1,045.50

R2 1,092.60

R3 1,122.35

Moving Average

20 SMA 953.68

50 SMA 1,179.39

100 SMA 1,375.48

200 SMA 1,468.54

Bharat Parenterals Ltd Corporate Actions

Dividend

Bonus

Splits

Rights

AGM

EGM

Bharat Parenterals Ltd

₹1/Share

Announcement Date 25 Jun 2024

Record Date 25 Jun 2024

Div Yield 10%

AGM Date: 27 Sep 2022

AGM 27/09/2022 We submit herewith 29th Annual Report of the company for the FY 2021-2022 together with the Notice of 29th Annual General Meeting of the company scheduled to be held on 27th September, 2022 at 10:30 A.M. through Video Conferencing (VC) or Other Audio-Visual Means (OAVM) in accordance with the relevant circulars issued by Ministry of Corporate Affairs (MCA) and SEBI. The said Annual Report along with the Notice is also available on the website of the company www.bplindia.in A copy of the Annual Report is being mailed to all the shareholders of the company whose E-Mails IDs are registered with the company/R&T Agents & DPs. We wish to inform you that 29th Annual General Meeting ('AGM') of the Company will be held on Tuesday, September 27,2022 at 10:30 A.M. (IST) at its Registered Office through Video Conferencing (VC) or Other Audio-Visual Means (OAVM) in accordance with the relevant circulars issued by Ministry of Corporate Affairs (MCA) and SEBI. Pursuant to Regulation 30 and 34 of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith notice convening the 29th Annual General Meeting (As Per BSE Announcement dated on 02.09.2022) As per the requirement of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, proceedings of the 29th Annual General Meeting held on 27th September, 2022 through Video Conferencing (VC)/other audio visual means (OAVM) of the Company is enclosed herewith. (As Per BSE Announcement dated on 27.09.2022) Pursuant to regulation 44 of SEBI (Listing Obligation and Disclosure Requirements) Regulations,2015 as amended, enclosed herewith the details of Voting results and Scrutinizer Report of 29th Annual General Meeting of the company held through Video Conferencing or Other Audio-Visual Means (OAVM) on 27th September,2022 at 10:30 A.M. (As per BSE Announcement Dated on 28/9/2022) In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, following resolutions are approved in the 29th Annual General Meeting of the company held on 27th September, 2022 (As per BSE Announcement Dated on 11/10/2022) In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, following resolutions are approved in the 29th Annual General Meeting of the company held on 27th September, 2022: 1. Reappointment of Statutory Auditors CNK & Associates LLP, Chartered accountants (ICAI Firm Registration No. 101961) for the second term of 5 years. 2. Approval of material related party transactions. 3. Approval of Increase in Authorized Share Capital of the company by Rs. 50,00,000/- (Rupees Fifty Only) divided into 5,00,000 (Five Lakhs) Equity Shares of Rs. 10/- (Rupees Ten Only) each and alteration of Memorandum of Association of the Company. 4. Reappointment of Mrs. Zankhana Sheth, Independent Director of the company. 5. Approval of Loans, Investment, Guarantee or security to be made under section 185 of Companies Act, 2013 to subsidiary company 'Varenyam Biolifesciences Private Limited' (As Per BSE Announcement Dated on 14.10.2022)

AGM Date: 30 Sep 2023

AGM 30/09/2023 We hereby submit the Notice of 30th AGM alongwith the Annual Report for the Financial Year 2022-23 of the Company. (As Per BSE Announcement Dated on 05.09.2023) Enclosed herewith the Proceedings of AGM held on 30.09.2023. (As per BSE Announcement Dated on 30/09/2023)

AGM Date: 02 Jul 2024

AGM 02/07/2024 The Intimation of 31st Annual General Meeting is Scheduled on 2nd July, 2024 and Record date/Cut off date as fixed for final dividend for FY 2023-2024 Intimation of Cut off date for E-voting for 31st Annual General Meeting of the Company (As Per BSE Announcement dated on 10.06.2024) Intimation of Revised Annual report fo fiancial year and quarter ended on 31st March, 2024. (As Per BSE Announcement dated on 25.06.2024) Proceedings/Transcript of 31st Annual General Meeting held on 2nd July,2024 (As Per BSE Announcement Dated on: 02/07/2024) Intimation of Voting result alongwith Scrutinizer''s report for 31st Annual General Meeting held on 2nd July, 2024 (As Per BSE Announcement Dated on 04.07.2024)

Bharat Parenterals Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceuticals Industries Ltd	₹1,748.60	₹4,19,547.71
Divis Laboratories Ltd	₹5,777.90	₹1,53,385.09
Cipla Ltd	₹1,508.70	₹1,21,844.87
Torrent Pharmaceuticals Ltd	₹3,135.60	₹1,06,118.19
Dr Reddys Laboratories Ltd	₹1,164.70	₹97,189.02

Bharat Parenterals Ltd Top Mutal Funds Invested

No data available

Bharat Parenterals Ltd News

Bharat Parenterals to announce Quarterly Result

On 3 February 2025

24 Jan 2025, 10:28 am

Bharat Parenterals to announce Quarterly Result

On 29 October 2024

21 Oct 2024, 10:22 am

Bharat Parenterals announces board meeting date

On 8 August 2024

01 Aug 2024, 10:54 am

Bharat Parenterals schedules AGM

On 2 July 2024

12 Jun 2024, 10:01 am

Bharat Parenterals to hold board meeting

On 10 June 2024

07 Jun 2024, 10:29 am

Bharat Parenterals Ltd Stock Analysis

Annual revenue for Bharat Parenterals Ltd increased by 12.37% to ₹266.11 crore in FY 2024 from ₹236.82 crore in FY 2023.
Annual Net Profit for Bharat Parenterals Ltd decreased by 7.16% to ₹22.59 crore in FY 2024 from ₹24.34 crore in FY 2023.
Promoter Shareholding in Bharat Parenterals Ltd remains unchanged by 0.00% in the most recent quarter, from 67.20% in October 2024 to 67.20% in December 2024.
Bharat Parenterals Ltd delivered a 1-year return of -14.26% compared to the Nifty 50, which provided a return of 0% as of the last trading session.
Bharat Parenterals Ltd share price moved up by 1.48% from its previous close of INR ₹998.40. The latest Bharat Parenterals Ltd share price is INR ₹1,013.15.
Bharat Parenterals Ltd share price today has been at a low of 980 and a high of 1,048. Over the past 52 weeks, the Bharat Parenterals Ltd share price has seen a low of 802 and a high of 1,870.